OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.23%540.331.0%$620.38m
DHRDanaher Corp. -0.10%297.320.7%$603.80m
ABTAbbott Laboratories -0.12%120.940.8%$567.87m
ISRGIntuitive Surgical, Inc. 1.02%991.462.3%$461.57m
MDTMedtronic Plc 0.46%131.280.6%$455.56m
ALGNAlign Technology, Inc. 2.78%695.806.3%$417.38m
NURONeuroMetrix, Inc. -7.11%14.907.7%$334.47m
DXCMDexCom, Inc. 13.04%515.517.8%$331.96m
SYKStryker Corp. 0.69%271.041.3%$324.45m
BSXBoston Scientific Corp. 0.71%45.641.0%$283.99m
AAgilent Technologies, Inc. 0.32%153.161.6%$279.08m
EWEdwards Lifesciences Corp. 0.56%112.240.4%$277.69m
BDXBecton, Dickinson & Co. 0.14%255.671.0%$258.67m
IDXXIDEXX Laboratories, Inc. -3.64%678.533.8%$248.19m
BAXBaxter International, Inc. 0.08%77.441.8%$219.11m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.